Histocompatibility Laboratory Bylaws and Policies Guidance Document

Slides:



Advertisements
Similar presentations
Membership and Personnel Requirements for VCA Programs (Resolution 27) Vascularized Composite Allograft (VCA)Transplantation Committee Sue V. McDiarmid,
Advertisements

UNOS Update.  Updating 2012 Strategic plan  Planning for OPTN and UNOS Strategic Planning RegionsBoard Executive Committee /CAC Community.
Histocompatibility Bylaws Rewrite: Phase 2 Histocompatibility Committee Fall 2014.
Proposal to Clarify Data Submission Reporting and Documentation Requirements (Resolution 22) Membership & Professional Standards Committee (MPSC) Jonathan.
1 Proposal to Revise OPTN/UNOS Data Release Policies Data Advisory Committee Fall 2015.
Greater Consistency in Candidate and Deceased Donor HLA Typing Requirements Across Organ Types Histocompatibility Committee Spring 2014.
Proposed Membership and Personnel Requirements for Intestine Transplant Programs Liver and Intestinal Organ Transplantation Committee Spring 2015.
Proposal to Require Reporting of Every Islet Infusion to the OPTN Contractor within 24 Hours of the Infusion Pancreas Transplantation Committee Fall 2012.
1 Addressing the Term “Foreign Equivalent” in OPTN/UNOS Bylaws Membership and Professional Standards Committee Fall 2015.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Fall 2014.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
1 Proposal to Update the HLA Equivalency Tables Histocompatibility Committee Fall 2015.
OPTN/UNOS HISTOCOMPATIBILITY COMMITTEE REPORT TO THE BOARD OF DIRECTORS JUNE 25-26, 2012 RICHMOND, VA Nancy L. Reinsmoen, PhD., Chair.
Membership & Professional Standards Committee (MPSC)
Histocompatibility Committee
Updating Primary Kidney Transplant Physician Requirements
Rewrite of Article II: Board of Directors
Pediatric Transplantation Committee
Minority Affairs Committee
Revisions to Pediatric Emergency Membership Exception
Pancreas Transplantation Committee
Thoracic Organ Transplantation Committee
Manipulation of the Waitlist Priority of the Organ Allocation System through the Escalation of Medical Therapies Ethics Committee.
Guidance on Optimizing VCA Recovery from Deceased Donors
Histocompatibility Committee
Histocompatibility Committee
Clarify Informed Consent of Transmittable Conditions
Pediatric Transplantation Committee
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Guidance for ABO Subtyping Organ Donors for Blood Groups A and AB
Thoracic Organ Transplantation Committee
OPTN/UNOS Kidney Transplantation Committee
Thoracic Organ Transplantation Committee Spring 2015
Addressing HLA Typing Errors
Guidance on Requested Deceased Donor Information
Membership and Professional Standards Committee
Histocompatibility Committee
Pediatric Transplantation Committee
OPTN/UNOS Thoracic Organ Transplantation Committee Dr. Joe Rogers
Updating the OPTN Definition of a Transplant Hospital
Pancreas Program Functional Inactivity
Thoracic Organ Transplantation Committee Spring 2019
Modify HOPE Act Variance to Include Other Organs
Ethical Implications of Multi-Organ Transplants (MOT)
Action Items from the Kidney Transplantation Committee
Living Donor Committee
Thoracic Organ Transplantation Committee
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
OPTN Histocompatibility Committee
Kidney Transplantation Committee
Kidney Transplantation Committee
Guidance on Effective Practices in Broader Distribution
Living Organ Donation by Persons with Certain Fatal Diseases who Meet the Criteria to be Living Organ Donors Ethics Committee.
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Membership & Professional Standards Committee
Policy Rewrite Parking Lot Quick Fixes
Clarify Informed Consent of Transmittable Conditions
Vascularized Composite Allograft Transplantation Committee Fall 2014
Nancy L. Reinsmoen, PhD, Chair
Region 8 Meeting Harvey Solomon, MD
Histocompatibility Committee
Histocompatibility Committee
OPTN/UNOS Histocompatibility Committee
Pancreas Transplantation Committee
MPSC Transplant Program Performance Measures (Outcome Measures)
VCA Committee Update Spring 2015.
Histocompatibility Committee
Histocompatibility Committee
OPTN/UNOS Histocompatibility Committee
Presentation transcript:

Histocompatibility Laboratory Bylaws and Policies Guidance Document Histocompatibility Committee

What problem will the proposal solve? Some policy and bylaw sections are better suited as guidance Some current histocompatibility bylaws and policies are vague As part of the histocompatibility comprehensive policy and bylaw rewrite in 2014, the Committee started this guidance document to provide clarity and suggested best practices for members on OPTN policies and bylaws. During the rewrite, the Committee identified 28 sections of policy that would be better suited for guidance because they were Difficult to monitor by UNOS Already standards required by ASHI or CAP Recommendations or suggestions for practice, not actual policies (i.e. not “must”s) The guidance document will help provide clarity for problems related to misinterpretation of the current OPTN/UNOS policies and bylaws.

What are the proposed solutions? Create guidance document as a tool for laboratories to provide clarity on OPTN policy and bylaws requirements Provide a template for best practices The guidance document contains what remains of the 28 original sections removed from policy and designated for the guidance document information for better compliance with histocompatibility policies and bylaws that were identified as potentially vague The Committee formed a Guidance Document Subcommittee (the Subcommittee). They reviewed the 28 sections individually and, along with the earlier considerations (difficult to monitor by UNOS, already standards required by ASHI or CAP, policies were really recommendations or suggestions and not “must”s) discussed whether certain sections were out of date and consequently no longer relevant or redundant to other existing policies.   After reviewing and paring down the original 28 sections, the Subcommittee drafted a guidance document with the remaining sections. The Subcommittee also created guidance for sections of the histocompatibility policies and bylaws identified by the Committee to be vague and that could benefit from clarification. Through several comprehensive edits, the Committee and Subcommittee continued to refine the document, ensuring that it was current and provided thoroughly considered suggestions for best practice.

Content included in guidance C.2 Facilities and Resources C.2.C: Written Agreements C.2.C #8: A process to obtain sensitization history for each patient C.2.C #9: The frequency of periodic sample collection C.2.C #11: The criteria for crossmatching C.2.C #12: The assay format that will be used for antibody screening and for crossmatching 4.4 Resolving Discrepant Donor and Recipient HLA Typing Results 4.6 Crossmatching 4.6.A Crossmatching for Kidney Transplants Physical Crossmatching Virtual Crossmatching 4.7 Blood Type Determination 4.8 Preservation of Excess Specimens These are the sections of current OPTN bylaws and policies that the Committee included guidance for in the document.

How will members implement this proposal? Member obligations won’t change (guidance not a policy change) Guidance document posted on OPTN website Guidance documents are meant to be informational and not requirements. As such, members will not need to do anything to implement this proposal. They can choose to follow the guidance provided if they see fit. The guidance document will be posted on the OPTN website and will be available to the histocompatibility laboratories and the public. This guidance document will address three of the OPTN goals: Improve waitlisted patient, living donor, and transplant recipient outcomes by a better understanding of histocompatibility testing practices to improve outcomes Promote living donor and transplant recipient safety by helping labs engage in high quality HLA testing and lab practices Promote the efficient management of the OPTN by assisting the community with necessary information to make informed decisions related to histocompatibility.

How will the OPTN implement this proposal? Anticipated Board approval: June 2017 Will post guidance document on OPTN website No programming required No instructional effort currently needed If approved by the Board, the guidance document will be posted on the OPTN website and will be available for both members and the general public to see. There will be no IT programming required for this project.

Questions? Robert A. Bray, Ph.D., D(ABHI), HCLD/CC(ABB) Committee Chair rbray@emory.edu Alison Wilhelm Committee Liaison alison.wilhelm@unos.org